Church & Dwight’s (CHD) earnings have grown at a strong double-digit rate in the past several quarters and have outpaced those of its rivals. The company has surpassed Wall Street’s expectations in five...
Church & Dwight’s (CHD) earnings have grown at a strong double-digit rate in the past several quarters and have outpaced those of its rivals. The company has surpassed Wall Street’s expectations in five...
Applications Open for Colgate-Palmolive's Annual Haz la U™ Educational Grant Program
In partnership with the Hispanic Heritage Foundation, Colgate-Palmolive continues its mission to empower Latinx high school students to pursue higher education NEW YORK , June 24, 2019 /PRNewswire/ -- Colgate-Palmolive...
The Board of Directors of Colgate-Palmolive Company today declared a quarterly cash dividend of $0.43 per common share, payable on August 15, 2019, to shareholders of record on July 18, 2019.
Colgate-Palmolive's (CL) improved organic sales and better-than-expected earnings have boosted its stock in the past two quarters.
While Colgate-Palmolive (CL) has beaten Wall Street’s EPS expectations in the past two quarters, its adjusted EPS have fallen in the past three quarters.
Whereas Colgate-Palmolive’s (CL) top line beat analysts' estimate in the first quarter, it has missed their estimates in four of the past five quarters.
Colgate-Palmolive (CL) stock has gained substantially this year, outperforming broader markets. The stock has risen 23.3%, while the S&P 500 has risen 15.3%. Let's look at what's boosted the stock.
Procter & Gamble (PG) emphasizes on improving its product portfolio through strategic initiatives. Also, the company is on track with its cost-saving plans.
Recently, 5 companies have managed to achieve 52-week highs
Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.
As one of the fastest-growing companies in cannabis, Cresco Labs leads industry across multiple disciplines. We are involved with every element of the seed-to-sales process – starting with state-of-the-art cultivation facilities, precisely designed to produce thriving cannabis plants. Our in-house lab team ensures product purity and quality before moving products through production, packaging, and shipment. We distribute our products to dispensaries nationwide, including several dispensaries owned and operated by our team.
ILLINOIS
We started our journey in the land of Lincoln, receiving the top 3 scores in the most competitive licensing process to date. Over 110,000 square feet of cultivation in three facilities yield enough product to service over 50 dispensaries across the entire state. In 2018, saw Cresco entered the retail space by acquiring three dispensary locations, with additional acquisitions pending regulatory approval.
PENNSYLVANIA
Cresco Labs moved into Pennsylvania with the second highest score of all submitted applications. Our facilities, located an hour outside of Pittsburgh, were the first to provide product to the state. The landmark first sale of medical marijuana happened out of our own Butler, PA dispensary in February, 2018. Since, Cresco has opened an additional location in Pittsburgh’s historic Strip District and an accompanying medical marijuana education center, serving as the epicenter for medical marijuana awareness and education in the state.